Churchill Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79M | Sell |
|
|||||
|
2025
Q1 | $12.8M | Sell |
|
|||||
|
2024
Q4 | $18.3M | Buy |
|
|||||
|
2024
Q3 | $21.1M | Sell |
|
|||||
|
2024
Q2 | $21.5M | Sell |
|
|||||
|
2024
Q1 | $19.3M | Sell |
|
|||||
|
2023
Q4 | $18.9M | Sell |
|
|||||
|
2023
Q3 | $17M | Sell |
|
|||||
|
2023
Q2 | $17.7M | Sell |
|
|||||
|
2023
Q1 | $16.7M | Sell |
|
|||||
|
2022
Q4 | $15.9M | Buy |
|
|||||
|
2022
Q3 | $2.31M | Buy |
|
|||||
|
2022
Q2 | $2.24M | Buy |
|
|||||
|
2022
Q1 | $2.06M | Buy |
|
|||||
|
2021
Q4 | $1.66M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.69M | Buy |
|
|||||
|
2020
Q2 | $1.46M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $22.8M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $30.5M | Buy |
|